Development & Clinical Application of K-PaC Registry Version 2.0
NCT ID: NCT07171515
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
6923 participants
OBSERVATIONAL
2023-01-02
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection from more than 811 enrolled patients from 2023 to 2029
* Creation of clinical evidence (RWE) based on pancreatic cancer real-world data (RWD): 3 or more
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan
NCT04984174
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
NCT02886247
Registry for Pancreatic Cancer
NCT03001505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang Myung Woo
Head, Center for Liver and Pancreatobiliary Cancer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Center
Goyang, Gyeonggido, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Study Protocol
1\. 1. Guidelines for the Pancreatic Cancer Registry, National Cancer Center Big Data
View DocumentDocument Type: Study Protocol
2\. CONNECT Cancer Big Data Library: Pancreatic Cancer Section
View DocumentDocument Type: Study Protocol
Korean clinical practice guideline for pancreatic cancer 2021
View DocumentRelated Links
Access external resources that provide additional context or updates about the study.
1\. Guidelines for the Pancreatic Cancer Registry, National Cancer Center Big Data Center
2\. CONNECT Cancer Big Data Library: Pancreatic Cancer Section
Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC2022-0061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.